Funding Opportunities

European & International Funding

number of European and International funds are available to UK based healthcare companies and researchers.

H2020: For a Better Innovation Support to SMEs
The following call for proposals is one element of a broader action to address these challenges and develop the ecosystem of innovation support to SMEs in Europe. Generally, the actions are designed to provide opportunities to Member States and regions to enhance their services through collaboration, and peer-learning. The emphasis is on further testing new approaches for better innovation support, such as blockchain technologies, workplace innovation, a network for Open Innovation, training on advanced manufacturing, experimentation in innovation agencies and a tool for investors in financing SMEs. These large pilot actions will consolidate the results and provide recommendations for the preparation of the next framework programme. The Enterprise Europe Network, the National Contact Points (NCPs) and the Member States are expected to continue playing an important role in implementing these pilot actions and transferring the result ‘in-real-time’ to their regions and managing authorities of their European Structural and Investment Funds (ESI Funds).
Deadline: 12th September 2019.
Click here for more information.

H2020: Industrial Leadership – Dedicated SME Instrument 2019
The SME Instrument provides full-cycle business innovation support. It has three phases, includes a coaching and mentoring service, and applications will be accepted throughout 2019 for Phase 1 and Phase 2:
•Phase 1: Feasibility study. Funding is a lump sum of €50,000 Projects should last around six months
•Phase 2: From concept to market. Grant funding is provided (funding rate 70%) of between €500,000 and €2.5 million. Projects should normally take 12 to 24 months to complete but could be longer in exceptional and well-justified cases.
•Phase 3: Commercialisation. Additional EU support extended via a range of business support services offered on the EIC Community Platform, open to SMEs benefiting from the different EIC calls for proposals.
Deadlines in 2019 for Phase 1 proposals are: 5 September; and 6 November 2019.
Deadlines in 2019 for Phase 2 proposals are: 9 October 2019.

Click here for more information.

EU Health Programme: Project Grants: Stakeholder actions to implement the EU guidelines
The main objectives of the present call for projects (stakeholders actions) are focused on the implementation of the EU guidelines on prudent use of antimicrobials in human health:
• to raise awareness and foster the direct application of the EU guidelines on the prudent use of antimicrobials by healthcare practitioners and members of the stakeholder organisations;
• to change practices on antimicrobial prescription and dispensing amongst members of the stakeholder organisations involved (in the project) in the direction of compliance with the guidelines;
• to reduce of inappropriate use of antimicrobials in human health. on prudent use of antimicrobials in human health.
Deadline: 10 September 2019, 5.00pm Brussels Time
Click here for more information.

EU Health Programme: Project Grant: Rare disease registries for the European Reference Networks
The main objectives of the present Call for projects for RD registries for ERNs are:
• to enable building, upgrading, linking and making interoperable registries covering the diseases and conditions of each ERN, thus linking and making visible patients cohorts at European level in order to follow up the natural course of diseases with sufficient patients data, also by registering all individual RD registries of the ERNs on the EU RD Platform;
• based on the above registration, to develop a comprehensive approach for rare disease registries covering the respective ERNs following the standards and tools provided by the EU RD Platform.
Deadline: 10 September 2019, 5.00pm Brussels Time
Click here for more information.

H2020: Widening Fellowships
The goal of the Individual Fellowships is to enhance the creative and innovative potential of experienced researchers, wishing to diversify their individual competence in terms of skill acquisition through advanced training, international and intersectoral mobility. Widening fellowships, in particular, provide specific support to researchers to undertake their fellowship in a widening country. This will help spread excellence and close the still apparent research and innovation gap within Europe.
Deadline: 11 September 2019
Click here for more information

H2020: Future and Emerging Technologies: Open Challenge Current Thinking
The challenge is to lay the foundations for radically new future technologies of any kind from visionary interdisciplinary collaborations that dissolve the traditional boundaries between sciences and disciplines, including the social sciences and humanities. This topic also encourages the driving role of new actors in research and innovation, including excellent young researchers, ambitious high-tech SMEs and first-time participants to FET under Horizon 2020 from across Europe.
Deadline: 18 September 2019
Click here for more information.

H2020: Marie Skłodowska-Curie Co-Funding for Fellowships and Doctorates
The COFUND scheme aims to stimulate regional, national or international programmes to foster excellence in researchers’ training, mobility and career development, spreading the best practices of the Marie Skłodowska-Curie actions.
This will be achieved by co-funding new or existing regional, national, and international programmes to open up to, and provide for, international, intersectoral and interdisciplinary research training, as well as transnational and cross-sectoral mobility of researchers at all stages of their career.
Deadline: 26 September 2019
Click here for more information

Horizon 2020: Anti-Superbugs PCP (Grant Agreement 688878)
Six leading European procuring entities, under the lead of AQuAS, challenge industry to develop smart ICT solutions able to detect the presence of resistant microorganisms, give real-time feedback to the user and at the same time share the information with the healthcare provider electronic record systems, linking the infection with the place of the detection.
The Available budget for the research, development and testing of these innovative solutions is 3.45 million Euro (VAT included).
The call documents will be published on the TED platform. The link is available on the project website here, and the public procurement platform here. The full administrative and technical details for the tender can be found here.

The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to a number of R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions.
Each selected operator will be awarded a framework agreement that covers 3 R&D phases:
• Phase 1: Up to solution design
• Phase 2: Up to a validated prototype
• Phase 3: Up to original development, validation and testing of a limited set of first products or services.
The procurement – from the tender procedure until the subsequent performance of contracts – is expected to start in 28/07/2019 and to end in 29/08/2021.
The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions beyond the Buyer Group.
This is a joint procurement involving different countries, and the state applicable national procurement law is the Spanish one.

The lead procurer (Agència de Qualitat i Avaluació Sanitària de Catalunya) is appointed to coordinate and lead the joint PCP, and to sign and award the framework agreement and the specific contracts for all phases of the PCP, in the name and on behalf of the following Buyers Group:
ICO/ VINCat (Catalan Institute of Oncology/Catalan Nosocomial Infections Surveillance Programme), Spain
UKA (Aachen University Hospital), Germany
STH (Sheffield Teaching Hospitals NHS Foundation Trust), UK on behalf of NIHR Devices for Dignity MedTech Co-operative
PAT (Provincia Autonoma di Trento), Italy
HELIOS (HELIOS Universitätsklinikum Wuppertal), Germany
FMT (Fundació Mutua de Terrassa), Spain.
The Lead Procurer is not part of the Buyers Group and the EU is not participating as a contracting authority in this procurement.
The consortium comprises also the following partners, who provide a scientific-technical and/or legal support :
RISE RESEARCH INSTITUTES OF SWEDEN AB – RISE
Sara Bedin, Independent expert on Innovation Public Procurement and PCP specialist
Deadline: 28 October 2019
For further information click here

European & Developing Countries Clinical Trials Partnership

New Drugs and Vaccines for Priority Pathogens in Antimicrobial Resistance 2019
The purpose of this call is to provide funding for clinical trials to be conducted in sub-Saharan Africa which aim to develop new or improved medicinal products (drugs and vaccines) or combinations thereof against pathogens from the WHO priority list that also fall within the scope of the EDCTP2 programme, specifically Campylobacter, Salmonella, Streptococcus pneumoniae, and Mycobacterium tuberculosis.
Proposals should include at least one clinical trial (phase I to IV) in sub-Saharan Africa. Proposals should clearly define the activities and mechanisms to be used within the project, including details of any collaboration with public authorities, international organisations or commercial partnerships that will be established in order to achieve the expected impact.
The total call budget is €18 million. It is expected that 2-4 grants will be awarded.
Deadline: 7 November 2019
Click here for more information.

Strategic Actions Supporting Large-scale Clinical Trials 2019
The purpose of this Call for Proposals is to support strategic actions (clinical research activities) that are part of a large-scale clinical trial with the potential to achieve rapid advances in the clinical development of new or improved medical interventions (drugs, vaccines, microbicides) or diagnostics, including multiplex diagnostic platforms, for PRDs. Proposals for a strategic action must focus on phase III/IV study(ies) or advanced field testing (in the case of diagnostics) on PRDs within the remit of the EDCTP2 programme. The proposed EDCTP2-funded study(ies) should be conducted in sub-Saharan Africa but may form part of a larger trial that is conducted globally.
The total call budget is €20 million. It is expected that 2-4 grants will be awarded.                            Deadline: 7 November 2019
Click here for more information.

Horizon Prize for Early Warning of Epidemics
The objectives of the prize are:
• to develop and demonstrate a scalable, reliable and cost-effective early warning system prototype using Earth Observation data to forecast and monitor vector-borne diseases;
• to contribute to the prevention of outbreaks mitigating their impact on local, regional and global scales and providing support to existing elimination efforts
The prize will be awarded to the entry that best addresses the following cumulative criteria:
– Criterion 1: Operational capability and integration of existing data (Max. 40pts)
– Criterion 2: Demonstrated implementation within an affected community (Max. 40 pts)
– Criterion 3: Scalability and sustainability of the Early Warning Concept (Max. 20 pts)
– Criterion 4: Focus on demonstration of European technology (Max. 20 points)
Deadline: 1 September 2020
Click here for more information

Horizon 2020: SME Instrument – Phase 2
The SME Instrument supports high-risk, high-potential small and medium-sized enterprises to develop and bring to market new products, services and business models that could drive economic growth.
Deadline: 7 October 2020
Click here to find out more.

Horizon 2020: SME Instrument – Phase 1
The SME Instrument supports high-risk, high-potential small and medium-sized enterprises to develop and bring to market new products, services and business models that could drive economic growth.
Deadline: 4 November 2020
Click here to find out more.

INTERNATIONAL

DIT – Tradeshow Access Programme
The Tradeshow Access Programme provides funding in the form of grants for eligible businesses to attend overseas trade shows. The funding helps your business gain: market knowledge; experience in attending and getting the most from overseas trade shows; advice and support from trade experts.
Deadline: open
Click here for more information